FDCDDQ
CLVS

Federation des caisses Desjardins du Quebec’s Clovis Oncology, Inc. CLVS Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,880
Closed -$12K – 2302
2020
Q1 		$12K Hold
1,880
– – ﹤0.01% 1627
2019
Q4 		$19.6K Buy
1,880
+1,100
+141% +$8K ﹤0.01% 1730
2019
Q3 		$3.06K Hold
780
– – ﹤0.01% 2045
2019
Q2 		$11.6K Hold
780
– – ﹤0.01% 1817
2019
Q1 		$19.4K Buy
+780
New +$19.6K ﹤0.01% 1521

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's CLVS Position: Q2 2020 in Review

Federation des caisses Desjardins du Quebec sold out of Clovis Oncology, Inc. (CLVS) in Q2 2020, closing a stake of 1,880 shares — an estimated $12K sold.

Federation des caisses Desjardins du Quebec first reported a position in CLVS in Q1 2019 and held it in 5 quarters. The position peaked at $19.6K in Q4 2019. 158 funds tracked by Wall St. Rank hold CLVS as of Q2 2020.

  • Federation des caisses Desjardins du Quebec reported no remaining Clovis Oncology, Inc. position as of Q2 2020 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 1,880 Clovis Oncology, Inc. shares in Q2 2020, an estimated $12K.
  • Federation des caisses Desjardins du Quebec first reported a position in Clovis Oncology, Inc. in Q1 2019 and held it in 5 quarters.
  • Federation des caisses Desjardins du Quebec's Clovis Oncology, Inc. position peaked at $19.6K in Q4 2019.
  • 158 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2020.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2020, filed 30 Aug 2024.